Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 2301 to 2350 of 2382

TitleReference numberPublishedLast updated
Urinary tract infection (lower): antimicrobial prescribingNG109
Urinary tract infection (recurrent): antimicrobial prescribingNG112
Urinary tract infection in children and young peopleQS36
Urinary tract infection in under 16s: diagnosis and managementNG224
Urinary tract infections in adultsQS90
URO17 for detecting bladder cancerMIB250
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaMTG58
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Ustekinumab for moderately to severely active Crohn's disease after previous treatmentTA456
Ustekinumab for the treatment of adults with moderate to severe psoriasisTA180
Ustekinumab for treating active psoriatic arthritisTA340
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Uterine artery embolisation for fibroidsIPG367
Uterine artery embolisation for treating adenomyosisIPG473
Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapseIPG584
VAAFT for treating anal fistulaeMIB102
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditionsIPG774
Vagus nerve stimulation for refractory epilepsy in childrenIPG50
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunctionIPG653
Vandetanib for treating medullary thyroid cancerTA550
Varenicline for smoking cessationTA123
Varicose veins in the legsQS67
Varicose veins: diagnosis and managementCG168
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)TA826
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Velmanase alfa for treating alpha-mannosidosisHST29
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanomaTA269
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemiaTA663
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemiaTA561
Venous thromboembolic diseases: diagnosis, management and thrombophilia testingNG158
Venous thromboembolism in adultsQS201
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolismNG89
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)TA675
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
VEST external stent for coronary artery bypass graftsMIB115
VibraTip for testing vibration perception to detect diabetic peripheral neuropathyMTG22
VIDAvision for lung volume analysis in emphysemaMIB148
Video laryngoscopes to help intubation in people with difficult airwaysMIB167
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tractTA272
Violence and aggression: short-term management in mental health, health and community settingsNG10
Violent and aggressive behaviours in people with mental health problemsQS154
Virtual chromoendoscopy to assess colorectal polyps during colonoscopyDG28

Results per page

  1. 10
  2. 25
  3. 50
  4. All